These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 21532277

  • 1. [Development of rapid genotyping methods for single nucleotide polymorphisms of cytochrome P450 2C9 (CYP2C9) and cytochrome P450 2C19 (CYP2C19) and their clinical application in pediatric patients with epilepsy].
    Yamamoto Y, Takahashi Y, Nishimura S, Ikumi Y, Mishima N, Kagawa Y.
    Yakugaku Zasshi; 2011; 131(5):809-15. PubMed ID: 21532277
    [Abstract] [Full Text] [Related]

  • 2. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K, Liu Y, Ai CZ, Yu X, Li W.
    Int J Clin Pharmacol Ther; 2018 Jul; 56(7):337-346. PubMed ID: 29628024
    [Abstract] [Full Text] [Related]

  • 3. Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms.
    Hung CC, Lin CJ, Chen CC, Chang CJ, Liou HH.
    Ther Drug Monit; 2004 Oct; 26(5):534-40. PubMed ID: 15385837
    [Abstract] [Full Text] [Related]

  • 4. Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.
    Kesavan R, Narayan SK, Adithan C.
    Eur J Clin Pharmacol; 2010 Jul; 66(7):689-96. PubMed ID: 20390258
    [Abstract] [Full Text] [Related]

  • 5. CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose.
    Chaudhry AS, Urban TJ, Lamba JK, Birnbaum AK, Remmel RP, Subramanian M, Strom S, You JH, Kasperaviciute D, Catarino CB, Radtke RA, Sisodiya SM, Goldstein DB, Schuetz EG.
    J Pharmacol Exp Ther; 2010 Feb; 332(2):599-611. PubMed ID: 19855097
    [Abstract] [Full Text] [Related]

  • 6. The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics.
    Mamiya K, Ieiri I, Shimamoto J, Yukawa E, Imai J, Ninomiya H, Yamada H, Otsubo K, Higuchi S, Tashiro N.
    Epilepsia; 1998 Dec; 39(12):1317-23. PubMed ID: 9860067
    [Abstract] [Full Text] [Related]

  • 7. Individualized phenytoin therapy for Japanese pediatric patients with epilepsy based on CYP2C9 and CYP2C19 genotypes.
    Yamamoto Y, Takahashi Y, Imai K, Miyakawa K, Ikeda H, Ueda Y, Yamaguchi T, Nasu H, Ohtani H, Shigematsu H, Kagawa Y, Inoue Y.
    Ther Drug Monit; 2015 Apr; 37(2):229-35. PubMed ID: 25162219
    [Abstract] [Full Text] [Related]

  • 8. Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms.
    Dorado P, López-Torres E, Peñas-Lledó EM, Martínez-Antón J, Llerena A.
    Pharmacogenomics J; 2013 Aug; 13(4):359-61. PubMed ID: 22641027
    [Abstract] [Full Text] [Related]

  • 9. Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese.
    Goto S, Seo T, Murata T, Nakada N, Ueda N, Ishitsu T, Nakagawa K.
    Ther Drug Monit; 2007 Feb; 29(1):118-21. PubMed ID: 17304159
    [Abstract] [Full Text] [Related]

  • 10. The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.
    Seven M, Batar B, Unal S, Yesil G, Yuksel A, Guven M.
    Mol Diagn Ther; 2014 Apr; 18(2):229-36. PubMed ID: 24338437
    [Abstract] [Full Text] [Related]

  • 11. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V, Perucca E.
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(8):1269-79. PubMed ID: 26037375
    [Abstract] [Full Text] [Related]

  • 12. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].
    Huang Y, Yang JF, Qi XL, Wang YQ, Wang WZ, Chen B.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 17; 84(20):1686-9. PubMed ID: 15569425
    [Abstract] [Full Text] [Related]

  • 13. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A, Hashimoto Y, Otsuki Y, Uwai Y, Hattori H, Furusho K, Inui K.
    Clin Pharmacol Ther; 1997 Sep 17; 62(3):287-92. PubMed ID: 9333104
    [Abstract] [Full Text] [Related]

  • 14. Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.
    Lee SY, Lee ST, Kim JW.
    J Biochem Mol Biol; 2007 May 31; 40(3):448-52. PubMed ID: 17562299
    [Abstract] [Full Text] [Related]

  • 15. Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.
    Lin CJ, Yen MF, Hu OY, Lin MS, Hsiong CH, Hung CC, Liou HH.
    Pharmacotherapy; 2008 Jan 31; 28(1):35-41. PubMed ID: 18154472
    [Abstract] [Full Text] [Related]

  • 16. Flow cytometric assay for genotyping cytochrome p450 2C9 and 2C19: comparison with a microelectronic DNA array.
    Pickering JW, McMillin GA, Gedge F, Hill HR, Lyon E.
    Am J Pharmacogenomics; 2004 Jan 31; 4(3):199-207. PubMed ID: 15174901
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters.
    Kanjanasilp J, Sawangjit R, Phanthaisong S, Borihanthanawuth W.
    Pharmacogenomics; 2021 Jul 31; 22(10):629-640. PubMed ID: 34060344
    [Abstract] [Full Text] [Related]

  • 18. Effect of CYP2C polymorphisms on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Hashimoto Y, Otsuki Y, Odani A, Takano M, Hattori H, Furusho K, Iui K.
    Biol Pharm Bull; 1996 Aug 31; 19(8):1103-5. PubMed ID: 8874828
    [Abstract] [Full Text] [Related]

  • 19. Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy.
    Lakhan R, Kumari R, Singh K, Kalita J, Misra UK, Mittal B.
    Indian J Med Res; 2011 Sep 31; 134(3):295-301. PubMed ID: 21985811
    [Abstract] [Full Text] [Related]

  • 20. Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin.
    Kidd RS, Curry TB, Gallagher S, Edeki T, Blaisdell J, Goldstein JA.
    Pharmacogenetics; 2001 Dec 31; 11(9):803-8. PubMed ID: 11740344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.